DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,536,116 | +0.8% | 82,772 | -2.5% | 0.23% | +4.9% |
| Q2 2023 | $20,372,302 | -23.1% | 84,886 | -19.2% | 0.22% | -25.2% |
| Q1 2023 | $26,478,696 | -13.4% | 105,059 | -8.8% | 0.30% | -14.6% |
| Q4 2022 | $30,580,546 | +1.5% | 115,217 | -1.2% | 0.35% | -5.4% |
| Q3 2022 | $30,126,000 | +3.2% | 116,639 | +1.3% | 0.37% | +7.6% |
| Q2 2022 | $29,202,000 | -12.8% | 115,188 | +0.9% | 0.34% | -3.4% |
| Q1 2022 | $33,480,000 | -11.2% | 114,134 | -0.3% | 0.36% | -5.1% |
| Q4 2021 | $37,688,000 | +15.8% | 114,513 | +7.0% | 0.37% | +8.7% |
| Q3 2021 | $32,559,000 | +11.9% | 107,015 | -1.3% | 0.34% | +19.4% |
| Q2 2021 | $29,107,000 | +19.6% | 108,477 | +0.4% | 0.29% | +5.9% |
| Q1 2021 | $24,333,000 | +9.8% | 108,027 | +8.2% | 0.27% | +6.7% |
| Q4 2020 | $22,160,000 | +3.9% | 99,808 | +0.9% | 0.26% | -10.5% |
| Q3 2020 | $21,319,000 | +21.8% | 98,963 | +0.0% | 0.28% | +12.2% |
| Q2 2020 | $17,497,000 | +12.9% | 98,953 | -11.6% | 0.25% | +17.6% |
| Q1 2020 | $15,496,000 | -2.2% | 112,000 | +8.4% | 0.22% | 0.0% |
| Q4 2019 | $15,852,000 | +7.4% | 103,280 | +1.0% | 0.22% | -2.3% |
| Q3 2019 | $14,760,000 | +0.9% | 102,276 | -0.1% | 0.22% | +0.9% |
| Q2 2019 | $14,623,000 | -6.9% | 102,365 | -14.0% | 0.22% | -14.1% |
| Q1 2019 | $15,714,000 | +24.4% | 119,024 | -2.9% | 0.26% | +11.4% |
| Q4 2018 | $12,636,000 | -5.4% | 122,593 | -0.3% | 0.23% | +8.5% |
| Q3 2018 | $13,353,000 | +33.5% | 122,911 | +21.2% | 0.21% | +26.3% |
| Q2 2018 | $10,005,000 | +1.7% | 101,416 | +0.9% | 0.17% | 0.0% |
| Q1 2018 | $9,838,000 | +13.3% | 100,516 | +7.4% | 0.17% | +9.9% |
| Q4 2017 | $8,684,000 | +9.1% | 93,624 | +1.0% | 0.15% | +0.7% |
| Q3 2017 | $7,963,000 | +3.7% | 92,689 | +1.8% | 0.15% | -1.9% |
| Q2 2017 | $7,682,000 | +2.1% | 91,051 | +3.6% | 0.15% | -2.5% |
| Q1 2017 | $7,527,000 | +14.1% | 87,865 | +3.9% | 0.16% | +5.3% |
| Q4 2016 | $6,595,000 | +0.1% | 84,552 | +0.9% | 0.15% | -3.2% |
| Q3 2016 | $6,590,000 | -30.4% | 83,811 | -10.7% | 0.16% | -29.2% |
| Q2 2016 | $9,472,000 | +3.0% | 93,806 | -3.2% | 0.22% | -1.8% |
| Q1 2016 | $9,192,000 | -3.8% | 96,957 | -5.7% | 0.22% | -5.5% |
| Q4 2015 | $9,553,000 | +11.4% | 102,853 | +2.4% | 0.24% | +4.0% |
| Q3 2015 | $8,575,000 | -16.7% | 100,478 | -16.3% | 0.23% | -13.7% |
| Q2 2015 | $10,288,000 | +6.5% | 120,023 | +5.4% | 0.26% | +5.6% |
| Q1 2015 | $9,661,000 | +0.1% | 113,922 | +1.3% | 0.25% | -2.4% |
| Q4 2014 | $9,656,000 | +10.9% | 112,493 | -1.8% | 0.26% | +4.9% |
| Q3 2014 | $8,707,000 | +35.1% | 114,583 | +40.1% | 0.24% | +33.5% |
| Q2 2014 | $6,447,000 | +5.2% | 81,776 | +0.3% | 0.18% | +1.1% |
| Q1 2014 | $6,127,000 | -4.1% | 81,557 | -1.5% | 0.18% | -2.7% |
| Q4 2013 | $6,390,000 | +10.9% | 82,782 | -0.5% | 0.18% | +2.8% |
| Q3 2013 | $5,762,000 | -34.8% | 83,175 | -40.5% | 0.18% | -33.3% |
| Q2 2013 | $8,834,000 | – | 139,698 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |